Borderline HbA2 levels: Dilemma in diagnosis of beta-thalassemia carriers
Tài liệu tham khảo
Weatherall, 2001
De Sanctis, 2017, β-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint, Mediterr. J. Hematol. Infect. Dis., 9, 10.4084/mjhid.2017.018
Thein, 2013, The molecular basis of β-thalassemia, Cold Spring Harb. Perspect. Med., 3, 10.1101/cshperspect.a011700
Giambona, 2009, The significance of the hemoglobin A2 value in screening for hemoglobinopathies, Clin. Biochem., 42, 1786, 10.1016/j.clinbiochem.2009.06.026
Mosca, 2009, The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies, J. Clin. Pathol., 62, 13, 10.1136/jcp.2008.056945
Steinberg, 2015, HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease, Br. J. Haematol., 170, 781, 10.1111/bjh.13570
Menzel, 2013, HbA2 levels in normal adults are influenced by two distinct genetic mechanisms, Br. J. Haematol., 160, 101, 10.1111/bjh.12084
Galanello, 1994, Genotype of subjects with borderline hemoglobin A2 levels: implication for, β‐thalassemia carrier screening, Am. J. Hematol., 46, 79, 10.1002/ajh.2830460204
Paleari, 2007, External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems, Clin. Chem. Lab. Med., 45, 88, 10.1515/CCLM.2007.002
Old, 2012
Li, 2011, Co-inheritance of β-and δ-thalassemia compromising prenatal screening in a Chinese couple seeking prevention, Fetal. Diagn. Ther., 30, 73, 10.1159/000321046
Colaco, 2012, Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases, Clin. Chim. Acta, 413, 1705, 10.1016/j.cca.2012.05.019
Paleari, 2018, Standardization of the HbA2 assay, EJIFCC., 29, 298
Stephens, 2015, ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2, Int. J. Lab. Hematol., 37, 577, 10.1111/ijlh.12413
Vinciguerra, 2012, Role of novel and rare nucleotide substitutions of the β-globin gene, Thalass. Rep., 2, e4, 10.4081/thal.2012.e4
Borgio, 2018, KLF1 gene and borderline hemoglobin A2 in Saudi population, Arch. Med. Sci., 14, 230, 10.5114/aoms.2018.72245
Al-Amodi, 2018, Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT), Curr. Med. Res. Opin., 34, 945, 10.1080/03007995.2018.1435520
Denic, 2013, Hemoglobin A2 lowered by Iron deficiency and α -Thalassemia: should screening recommendation for β -Thalassemia change?, ISRN Hematol., 10.1155/2013/858294
Al Moamen, 2013, Silent β-thalassemia mutations at -101 (C&T) and -71 (C&T) and their coinheritance with the sickle cell mutation in Bahrain, Hemoglobin, 37, 369, 10.3109/03630269.2013.785434
Paglietti, 2016, The problem of borderline hemoglobin A2 levels in the screening for β-thalassemia carriers in sardinia, Acta Haematol., 135, 193, 10.1159/000442194
Satthakarn, 2020, Molecular characterization of β-and α-Globin gene mutations in individuals with borderline hb A2 levels, Hemoglobin, 349, 10.1080/03630269.2020.1826327
Lou, 2014, Delineation of the molecular basis of borderline hemoglobin A2 in Chinese individuals, Blood Cells Mol. Dis., 53, 261, 10.1016/j.bcmd.2014.04.005
Jiang, 2018, Analysis of the genotypes in a chinese population with increased hb A2 and low hematological indices, Hemoglobin, 42, 154, 10.1080/03630269.2018.1509869
Fucharoen, 2002, Molecular analysis of a Thai β-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening, Ann. Clin. Biochem., 39, 44, 10.1258/0004563021901720
Perseu, 2011, KLF1 gene mutations cause borderline HbA2, Blood, 118, 4454, 10.1182/blood-2011-04-345736
Rangan, 2011, β-Thalassemia mutations in subjects with borderline HbA2 values: a pilot study in North India, Clin. Chem. Lab. Med., 49, 2069, 10.1515/CCLM.2011.696
Bilic, 2004, Masked deficit of vitamin B12 in the patient with heterozygous b-thalassemia and spastic paraparesis, Acta Neurol. Belg., 104, 173
Gupta, 2009, Cation exchange high performance liquid chromatography for diagnosis of haemoglobinopathies, Med. J. Armed Forces India, 65, 33, 10.1016/S0377-1237(09)80051-8
Bhagat, 2016, Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs, Infect. Dis., 48, 122, 10.3109/23744235.2015.1089592
Routy, 1993, Increase of hemoglobin A2 in human immunodeficiency virus‐1‐infected patients treated with zidovudine, Am. J. Hematol., 43, 86, 10.1002/ajh.2830430203
Kuhn, 1983, Influence of thyroid status on hemoglobin A2 expression, J. Clin. Endocrinol. Metab., 57, 344, 10.1210/jcem-57-2-344
Jaafar, 2009, The influence of thyroid hormones on hemoglobin a2 and F expression, New Iraqi J. Med., 5, 78
Batterbee, 2010
Paleari, 2017, Developing a reference system for the IFCC standardization of HbA2, Clin. Chim. Acta, 476, 21, 10.1016/j.cca.2016.05.023
Paleari, 2018, Calibration by commutable control materials is able to reduce inter-method differences of current high-performance methods for HbA2, Clin. Chim. Acta, 477, 60, 10.1016/j.cca.2017.12.001
De la Salle, 2019, Evaluation of the suitability of the World Health Organization International Reference Reagent for Hb A2 quantitation (89/666) for continued use, Int. J. Lab. Hematol., 41, 262, 10.1111/ijlh.12966
Kattamis, 1979, The heterogeneity of normal Hb A2-beta thalassaemia in Greece, Br. J. Haematol., 42, 109, 10.1111/j.1365-2141.1979.tb03703.x
Marongiu, 2016, Different switching patterns of β-thalassaemic mutations at the proximal and distal CACCC box of the human HBB (β-globin) gene, Br. J. Haematol., 173, 786, 10.1111/bjh.13636
Huisman, 1997, Levels of Hb A2 in heterozygotes and homozygotes for beta-thalassemia mutations; influence of mutations in the CACCC and ATAAA motifs of the beta-globin gene promoter, Acta Haematol., 98, 187, 10.1159/000203622
Ropero, 2017, Phenotype of mutations in the promoter region of the β-globin gene, J. Clin. Pathol., 70, 874, 10.1136/jclinpath-2017-204378
Rosatelli, 1995, A promoter mutation, C&T at position -92, leading to silent beta-thalassaemia, Br. J. Haematol., 90, 483, 10.1111/j.1365-2141.1995.tb05182.x
Ristaldi, 2001, Normal delta globin gene sequence in carrier of the silent-101 (C-T) beta-thalassemia mutation with normal HbA2 level, Am. J. Hematol., 67, 58, 10.1002/ajh.1079
Moi, 2004, A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF, Br. J. Haematol., 126, 881, 10.1111/j.1365-2141.2004.05146.x
Aguilar-Martinez, 2007, A novel mutation of the beta-globin gene promoter (-102 C&A) and pitfalls in family screening, Am. J. Hematol., 87, 1088, 10.1002/ajh.21000
Letitia, 2011, A novel β-globin gene CAP site mutation in association with the 92+ 1G& A mutation was found in a thalassemia intermedia patient, Rom. Biotechnol. Lett., 16, 6043
Wong, 1987, Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA, Nature, 330, 384, 10.1038/330384a0
Nadkarni, 1995, Clinical heterogeneity of silent-gene β-thalassemia among Indians, Ann. Hematol., 70, 61, 10.1007/BF01715386
Colah, 2007, Assessing the impact of screening and counselling high school children for beta-thalassaemia in India, J. Med. Screen., 14, 158, 10.1258/096914107782066202
Athanassiadou, 1994, A novel beta-thalassaemia mutation in the 5’ untranslated region of the beta-globin gene, Br. J. Haematol., 88, 307, 10.1111/j.1365-2141.1994.tb05023.x
Oner, 2001, Beta-Thalassaemia intermedia in a Turkish girl: homozygosity for G-->A substitution at +22 relative to the beta-globin cap site, Br. J. Haematol., 115, 90, 10.1046/j.1365-2141.2001.03071.x
Sgourou, 2004, Thalassaemia mutations within the 5’UTR of the human beta-globin gene disrupt transcription, Br. J. Haematol., 124, 828, 10.1111/j.1365-2141.2004.04835.x
De, 2004, β+45 G& C: a novel silent β-thalassaemia mutation the first in the Kozak sequence, Br. J. Haematol., 124, 224, 10.1046/j.1365-2141.2003.04754.x
Huang, 1991, A novel beta-thalassaemia mutation: deletion of 4 bp (-AAAC) in the 5’ transcriptional sequence, Br. J. Haematol., 78, 125, 10.1111/j.1365-2141.1991.tb04396.x
Patrinos, 2004, Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies, Nucleic Acids Res., 32, D537, 10.1093/nar/gkh006
Kountouris, 2014, IthaGenes: an interactive database for haemoglobin variations and epidemiology, PLoS One, 9, 10.1371/journal.pone.0103020
Fokkema, 2011, LOVD v.2.0: the next generation in gene variant databases, Hum. Mutat., 32, 557, 10.1002/humu.21438
Tzetis, 1994, The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece, Hematol. Pathol., 8, 25
Giordano, 2005, A new polyadenylation site mutation associated with a mild beta-thalassemia phenotype, Haematologica., 90, 551
Italia, 2012, Is the poly A (T& C) mutation a causative factor for misdiagnosis in second trimester prenatal diagnosis of β-thalassemia by fetal blood analysis on high performance liquid chromatography?, Hemoglobin, 36, 114, 10.3109/03630269.2011.654144
Italia, 2012, Variable haematological and clinical presentation of β‐thalassaemia carriers and homozygotes with the Poly A (T&C) mutation in the Indian population, Eur. J. Haematol., 89, 160, 10.1111/j.1600-0609.2012.01810.x
Sgourou, 2002, The beta-globin C-->G mutation at 6 bp 3’ to the termination codon causes beta-thalassaemia by decreasing the mRNA level, Br. J. Haematol., 118, 671, 10.1046/j.1365-2141.2002.03627.x
Bilgen, 2013, Two novel mutations in the 3’ untranslated region of the beta-globin gene that are associated with the mild phenotype of beta thalassemia, Int. J. Lab. Hematol., 35, 26, 10.1111/j.1751-553X.2012.01456.x
Divoky, 1994, The T>C mutation at position +96 of the untranslated region 3’ to the terminating codon of the beta-globin gene is a rare polymorphism that does not cause a beta-thalassemia as previously ascribed, Hum. Genet., 93, 77, 10.1007/BF00218918
Vinciguerra, 2016, Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia, Int. J. Lab. Hematol., 38, 17, 10.1111/ijlh.12433
Herrera, 2015, Identification of a Novel Mutation in the β Globin Gene 30 Untranslated Region (HBB: c.*+118A4G) in Spain, Hemoglobin, 39, 30, 10.3109/03630269.2014.995805
Rungsee, 2017, Detection of the common South-East Asian β0-thalassemia mutations in samples with borderline HbA2 levels, Clin. Chem. Lab. Med., 55, e17, 10.1515/cclm-2016-0470
Rosnah, 2017, The diagnosis of Beta thalassemia with borderline HbA2 level among Kelantan population, J. Blood Disord. Transfus., 8, 2
Colah, 2004, Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India, Blood Cells Mol. Dis., 33, 153, 10.1016/j.bcmd.2004.05.002
Nadkarni, 2001, Molecular pathogenesis and clinical variability of β‐thalassemia syndromes among Indians, Am. J. Hematol., 68, 75, 10.1002/ajh.1156
He, 2018, Molecular characterization of α- and β-thalassemia in the Yulin region of Southern China, Gene., 655, 61, 10.1016/j.gene.2018.02.058
Rahim, 2008, Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran. J. Ped. Hematol. Oncol., 13, 59
Musumeci, 1978, Thalassaemia of intermediate severity resulting from the interaction between alpha- and beta-thalassaemia, J. Med. Genet., 15, 448, 10.1136/jmg.15.6.448
Hassan, 2015, Hb Lansing (HBA2: c.264C > G) and a new β promoter transversion [-52 (G > T)]: an attempt to define the phenotype of two mutations found in the Omani population, Hemoglobin, 39, 111, 10.3109/03630269.2015.1016615
Cadet, 2009, First identification of a point mutation at position -83 (G>A) of the beta-globin gene promoter, Hemoglobin, 33, 274, 10.1080/03630260903081323
Panigrahi, 2004, High frequency of deletional alpha-thalassemia in beta-thalassemia trait: implications for genetic counseling, Am. J. Hematol., 76, 297, 10.1002/ajh.20083
Mehta, 2015, Colah RB Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes, Ann. Hematol., 94, 1953, 10.1007/s00277-015-2479-8
Moosavi, 2011, The carrier frequency of α-globin gene triplication in an Iranian population with normal or borderline hematological parameters, Hemoglobin, 35, 323, 10.3109/03630269.2011.571527
Frischknecht, 2007, A 65 bp duplication/insertion in exon II of the beta globin gene causing beta0-thalassemia, Haematologica, 92, 423, 10.3324/haematol.10785
Theodoridou, 2018, Compound Heterozygosity for Silent Cap+ 1570 (T>C)(HBB: c* 96T> C), Codon 39 (C> T)(HBB: c. 118C> T) and the Presence of ααα anti–3.7/αα in Greece. A Case Presentation, Hemoglobin, 42, 194, 10.1080/03630269.2018.1495648
Giordano, 2009, Frequency of alpha-globin gene triplications and their interaction with beta-thalassemia mutations, Hemoglobin, 124, 124, 10.1080/03630260902827684
Gorivale, 2015, Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner, Prenat. Diagn., 35, 1353, 10.1002/pd.4706
Jiang, 2015, Association of an α-Globin gene cluster duplication and heterozygous β-Thalassemia in a patient with a severe thalassemia syndrome, Hemoglobin, 39, 102, 10.3109/03630269.2015.1012678
Oggiano, 1994, A novel mediterranean “δβ‐thalassemia” determinant containing the δ+ 27 and β° 39 point mutations in cis, Am. J. Hematol., 45, 81, 10.1002/ajh.2830450113
Olds, 1991, A novel δo mutation in cis with Hb Knossos: a study of different genetic interactions in three Egyptian families, Br. J. Haematol., 78, 430, 10.1111/j.1365-2141.1991.tb04460.x
Loudianos, 1991, Molecular basis of the delta thalassemia in cis to hemoglobin Knossos variant, Blood., 77, 2087, 10.1182/blood.V77.9.2087.2087
Lacerra, 2010, Genotype-phenotype relationship of the δ-thalassemia and Hb A2 variants: observation of 52 genotypes, Hemoglobin., 34, 407, 10.3109/03630269.2010.511586
Morgado, 2007, Mutational spectrum of delta‐globin gene in the Portuguese population, Eur. J. Haematol., 79, 422, 10.1111/j.1600-0609.2007.00949.x
Valaei, 2012, Co-inheritance of beta & delta-globin gene (HbYialousa) mutations in an iranian β-thalassemia carrier, Int. J. Clin. Med., 3, 633, 10.4236/ijcm.2012.37113
So, 2011, Hb A2 Hong Kong–a novel δ-globin variant in a Chinese family masks the diagnosis of β-thalassemia trait, Hemoglobin, 35, 162, 10.3109/03630269.2011.557172
Waye, 2003, β‐thalassemia in association with a new δ‐chain hemoglobin variant [δ116 (g18) Arg→ Leu]: Implications for carrier screening and prenatal diagnosis, Am. J. Hematol., 74, 179, 10.1002/ajh.10423
Phylipsen, 2010, New and known β-thalassemia determinants masked by known and new δ gene defects [Hb A2-Ramallah or δ6 (A3) Glu→ Gln, G AG>> C AG], Hemoglobin, 34, 445, 10.3109/03630269.2010.511591
Colaco, 2014, Masking of a beta thalassaemia determinant by a novel delta globin defect [HbA2- Saurashtra or δ100(G2)Pro>Ser, HBDc.301C>T] in cis, Hemoglobin, 38, 24, 10.3109/03630269.2013.852568
Wood, 1977, Heterocellular hereditary persistence of fetal haemoglobin (heterocellular HPFH) and its interaction with β thalassaemia, Br. J. Haematol., 36, 461, 10.1111/j.1365-2141.1977.tb00986.x
Garner, 2003, Heterocellular hereditary persistence of fetal haemoglobin affects the haematological parameters of β-thalassaemia trait, Br. J. Haematol., 123, 353, 10.1046/j.1365-2141.2003.04600.x
Waye, 2015, Krüppel‐like factor 1: hematologic phenotypes associated with KLF1 gene mutations, Int. J. Lab. Hematol., 37, 78, 10.1111/ijlh.12356
Hariharan, 2019, Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders, Genomics, 111, 1771, 10.1016/j.ygeno.2018.11.032
Hariharan, 2017, Does the Novel KLF1 Gene Mutation Lead to a Delay in Fetal Hemoglobin Switch?, Ann. Hum. Genet., 81, 125, 10.1111/ahg.12191
Singleton, 2008, Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype, Blood, 12, 2081, 10.1182/blood-2008-03-145672
Kattamis, 1972, Serum iron and unsaturated iron-binding capacity in the-thalassaemia trait: their relation to the levels of haemoglobins A, A 2, and F, J. Med. Genet., 9, 154, 10.1136/jmg.9.2.154
El‐Agouza, 2002, The effect of iron deficiency anemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis, Clin. Lab. Haematol., 24, 285, 10.1046/j.1365-2257.2002.00464.x
Chopra, 2008, Spectrum of haemoglobinopathies in a tertiary care hospital of armed forces, Med. J. Armed Forces India, 64, 311, 10.1016/S0377-1237(08)80005-6
Yavarian, 2011, Impact of Iron deficiency anemia on HbA2 levels, J. Appl. Hematol., 200
Galanello, 1981, Hemoglobin A2 in iron deficient β-thalassemia heterozygotes, Hemoglobin, 5, 613, 10.3109/03630268108991694
Kurlekar, 1981, Haemoglobin A2 levels in iron deficiency anemia, Indian J. Med. Res., 73, 77
Passarello, 2012, Iron deficiency does not compromise the diagnosis of high HbA2 β thalassemia trait, Haematologica, 97, 472, 10.3324/haematol.2011.052357
Verhovsek, 2012, Is HbA2 level a reliable diagnostic measurement for β‐thalassemia trait in people with iron deficiency?, Am. J. Hematol., 87, 114, 10.1002/ajh.22188
Sharma, 2015, Impact of iron deficiency on hemoglobin A2% in obligate β‐thalassemia heterozygotes, Int. J. Lab. Hematol., 37, 105, 10.1111/ijlh.12246